RNA Clinical Trials Resources
-
How A Strategic Bioanalysis CRO Partnership Empowers Sponsors
1/8/2026
Choosing the right bioanalysis CRO is vital to avoid costly delays. Sponsors need evaluation strategies that prioritize proven quality, predictable timelines, and submission-ready data.
-
Europe At A Crossroads: Biotech Investment, Regulation, And Partnership In Real Life
12/10/2025
Position your biotech for Europe’s next phase by aligning strong science, smart clinical strategy, and the right global partners to navigate funding, regulation, and growth.
-
Enhancing Preclinical Analytics to Drive Clinical Success
12/9/2025
Bioanalysis is crucial for biopharma success. Here, Dash Bio’s Ander Tallett discusses selecting a bioanalysis CRO and collaborating effectively for assay results that accelerate drug development.
-
5 Questions That Put Sponsors Back in Control of Bioanalysis Projects
12/9/2025
Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.
-
ESMO Congress 2025: Highlights From Berlin
11/24/2025
Turn the insights from last year’s ESMO into action by partnering to accelerate innovation through smarter trial design, stronger biomarker planning, and truly global collaboration.
-
How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?
11/7/2025
By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.
-
Highlights From The 2025 International Hepatitis B Meeting
11/7/2025
For biotech and pharmaceutical teams, the core message was clear: progress is accelerating, but success still depends on smart study design, fit-for-purpose endpoints, and operational execution.
-
Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025)
11/7/2025
Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.
-
Using AI Tools In Hepatology Drug Development
10/27/2025
Explore how AI can help overcome key challenges in hepatology trials — from site selection and patient matching to data integration and engagement — while ensuring diversity, privacy, and transparency.
-
The Evolving RNA Landscape: Navigating Science, Strategy, And Global Markets
10/27/2025
Learn how to streamline development, reduce costs, and accelerate the path to market for next-generation RNA therapies.